ANVISA’s Participation in WHO: Impacts on the Regulation of Medical Products

WHO meeting discusses regulation of counterfeit medical products with participation of ANVISA.

Understand the Importance of ANVISA’s Role in the Global Product Regulation ANVISA is participating in the 13th plenary meeting of the Member States Mechanism on Substandard and Falsified Medical Products (MSMSF) of the World Health Organization (WHO), reinforcing its essential role in product regulation at the international level. The event will take place between November […]